December 2020 - PharmaTimes

December 2020 - PharmaTimes
Published on 3 December 2020

Description:

Pharmatimes Review of The Year 2020

Categories:

PharmaTimes

Preview:

25 articles from this collection:
Cover
Cover
2 - Clarity Pharma
2 - Clarity Pharma
3 - From the editor
3 - From the editor
TO DO - 4-5 Contents
TO DO - 4-5 Contents
6 - Star OUTiCO
6 - Star OUTiCO
The Royal Society of Chemistry has announced that its near 180-year old archive of research insights has been made available for Text and Data Mining projects, but why is this important? Richard Kidd, Head of Chemistry Data at the Royal Society of Chemistry, explores the significance
7 - COVID-19 NEWS
7 - COVID-19 NEWS
The most advanced of the experimental coronavirus vaccines are providing glimmers of hope for advancing the battle against COVID-19, having reported late-stage data with higher than expected levels of protection.
8 Medicine News
8 Medicine News
Six medicines have taken a leap towards approval having won the backing of the European Medicines Agency's human medicines committee (CHMP).
9 Hot or Not
9 Hot or Not
10 - Research News
10 - Research News
The National Institute for Health Research (NIHR) has launched five national patient recruitment centres (NPRCs) in a move designed to accelerate the delivery of late-stage clinical research within the NHS.
11 - Insight
11 - Insight
A new, pooled analysis of data from Novo Nordisk’s Phase III trials SUSTAIN 6 and PIONEER 6 shows that semaglutide may help patients with type 2 diabetes live longer without a cardiovascular event. PharmaTimes talks to lead study investigator Dr Jan Westerink about the importance of these findings
12 - ICON advert
12 - ICON advert
13-14 - The digital highway
13-14 - The digital highway
Digital has been waiting for pharma to join the party for a very long time. In the last few years, however, our industry has finally hit the digital dance floor, inviting the production line of constantly evolving technology to help extend, transform and save lives. Since March, digital has also entered all our consciousness in a truly existential way – a way none of us could have predicted. Indeed, if there was anyone left in our industry that hadn’t realised the digital age was upon us, please be assured, they do now.
15 - Syneos
15 - Syneos
16-17 - ROTY - A critical juncture
16-17 - ROTY - A critical juncture
At the beginning of January this year, there was a brief news report about a virus in Wuhan that appeared to be quite virulent. That seems so long ago, yet the year has flown. Hopefully, before we know it, we will be reflecting on what we all did during lockdown and looking ahead to the challenges of 2021.
18-20 - ROTY - Responding to the crisis
18-20 - ROTY - Responding to the crisis
At the start of this year, the NHS was working on the next stage of its Long Term Plan and defining how key aspects, such as integrated systems and moving more care out of hospitals, would work in practice.
21 - BMS
21 - BMS
One of the things I will remember most vividly about this year is the glimpse it has given me of what it means to be separated from those we care about.
22-24 - ROTY - Movers and shakers
22-24 - ROTY - Movers and shakers
M&A volumes more than doubled between 2005 and 2019. By comparison, 2020 has been a slow year, with a marked decline in deal activity and a sharp drop in overall deal value.
26-27 - ROTY 2020 - Patient 2020
26-27 - ROTY 2020 - Patient 2020
28-29 - ROTY - R&D Trends
28-29 - ROTY - R&D Trends
30-31 - ROTY - Planning for the unpredictable
30-31 - ROTY - Planning for the unpredictable
32-42 INTCR coverage
32-42 INTCR coverage
43-44 - ROTY - Targeting treatment
43-44 - ROTY - Targeting treatment
45-46 - Appointments
45-46 - Appointments
47 - Clinical Researcher of the Year - The Americas Awards
47 - Clinical Researcher of the Year - The Americas Awards
48 - International Clinical Researcher Awards
48 - International Clinical Researcher Awards